WaveMan · Form 4
Romanelli Joseph insider trades
> Search tickers & screens ⌘K
LIVE

Romanelli Joseph insider trades

Romanelli Joseph has filed 12 Form 4s with the SEC that we hold, for Merck & Co., Inc. (MRK) (President, Human Health Int?l) and Kimberly Clark Corp (KMB) (Director). Across all of them we count 8 purchases worth $44.3K and 5 sales worth $679.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 5,000 shares of Merck & Co., Inc. worth $541.1K, dated 2023-02-15. The first filing on our record is dated 2023-02-16 and the latest 2026-01-28.

Merck & Co., Inc. (MRK)

President, Human Health Int?l · 9 filings · 13 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-12-02P, purchase reported on Form 459$6.5K2023-06-30
2022-12-05P, purchase reported on Form 4107$11.7K2023-06-30
2022-12-06P, purchase reported on Form 430$3.3K2023-06-30
2022-12-13P, purchase reported on Form 456$6.2K2023-06-30
2022-12-19P, purchase reported on Form 47$7632023-06-30
2023-02-15S, sale reported on Form 45,000$541.1K2023-02-16
2023-02-21P, purchase reported on Form 411$1.2K2023-06-30
2023-03-20P, purchase reported on Form 4136$14.3K2023-06-30
2023-03-24S, sale reported on Form 435$3.7K2023-06-30
2023-04-26P, purchase reported on Form 43$3412023-06-30
2023-08-02S, sale reported on Form 459$6.3K2023-08-03
2023-08-02S, sale reported on Form 430$3.2K2023-08-03
2024-02-13S, sale reported on Form 41,000$124.9K2024-02-14

Kimberly Clark Corp (KMB)

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1938322) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms